Hawley, Tuberville Stand Against Big Pharma’s End-Run Around Rural Health Care

0
277

Democrats will spend 2026 blaming Medicaid reforms and expired Obamacare subsidies for healthcare problems in red states. They won’t mention the bigger threat: pharmaceutical companies rewriting the rules of a federal drug discount program that’s kept rural hospitals afloat for three decades.

The 340B Drug Pricing Program has been around for more than 30 years. Drug manufacturers who want to participate in Medicare and Medicaid—and collect billions in taxpayer dollars—have to offer discounted prices on outpatient drugs to safety-net hospitals and community health centers. These facilities then use those savings to provide services that wouldn’t otherwise be financially viable in rural communities.

According to new survey data from Advocates for Community Health, about 25% of the total savings large community health centers generate through 340B purchases…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here